Intranasal midazolam for prolonged convulsive seizures

Basit Öğe Kaydı
dc.authoridKutlu, Nurettin Onur/0000-0002-3306-6570
dc.authoridDURMAZ, YASAR/0000-0002-4437-0068
dc.authoridYakıncı, Mehmet Cengiz/0000-0001-5930-4269
dc.authoriddurmaz, yasar/0000-0002-4437-0068
dc.authorwosidKutlu, Nurettin Onur/AAW-6196-2021
dc.authorwosidDURMAZ, YASAR/JVO-4824-2024
dc.authorwosidYakıncı, Mehmet Cengiz/ABI-7519-2020
dc.authorwosiddurmaz, yasar/AAR-4655-2020
dc.contributor.authorKutlu, NO
dc.contributor.authorYakinci, C
dc.contributor.authorDogrul, M
dc.contributor.authorDurmaz, Y
dc.date.accessioned2024-08-04T20:12:07Z
dc.date.available2024-08-04T20:12:07Z
dc.date.issued2000
dc.departmentİnönü Üniversitesien_US
dc.description.abstractIn order to determine the efficiency of intranasal midazolam in prolonged convulsive episodes, we conducted a prospective study in children with various types of seizures. Nine patients (six buys, three girls; age range 6 months to 9 years) with prolonged convulsions lasting more than 10 min were treated with intranasal midazolam, 0.3 mg/kg. The success rate was 100% with only one case requiring a second dose. Estimated duration of seizures was 12-30 min (mean 18.6) while mean time elapsed until cessation of seizures was 139.6 s (range 60-480). No significant adverse effects were noted except fur one patient who had seizures secondary to serious CNS infection and respiratory depression after intranasal midazolam. (C) 2000 Elsevier Science B.V. All rights reserved.en_US
dc.identifier.doi10.1016/S0387-7604(00)00155-8
dc.identifier.endpage361en_US
dc.identifier.issn0387-7604
dc.identifier.issn1872-7131
dc.identifier.issue6en_US
dc.identifier.pmid11042416en_US
dc.identifier.scopus2-s2.0-0033784160en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage359en_US
dc.identifier.urihttps://doi.org/10.1016/S0387-7604(00)00155-8
dc.identifier.urihttps://hdl.handle.net/11616/93221
dc.identifier.volume22en_US
dc.identifier.wosWOS:000165101500001en_US
dc.identifier.wosqualityQ2en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherElsevier Science Bven_US
dc.relation.ispartofBrain & Developmenten_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectintranasal midazolamen_US
dc.subjectseizureen_US
dc.subjectchildhooden_US
dc.titleIntranasal midazolam for prolonged convulsive seizuresen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu